Health Tech V
The HealthTech V project (2011-2016) concluded five consecutive generations and nearly 30 years of the HealthTech projects. These projects identified and advanced technology solutions for the most pressing health issues in the developing world. Led by PATH, in partnership with the Public Health Institute, the International Federation of Gynecology and Obstetrics, WHO, and UNICEF, HealthTech V continued the preceding generations of HealthTech innovations with an emphasis on needs assessment, technology design and development, and introduction and scale-up to the field through distribution, marketing, and licensing activities.
The Project developed, evaluated, and facilitated the introduction of affordable and appropriate technology solutions for safe, effective, and equitable health care services in low and middle income countries. HealthTech V addressed issues with product design, supply chain, and policy that typically prevent innovative technologies from reaching poor and rural populations. The Project’s notable accomplishments include evaluating and introducing nine technologies in the field. These include evaluating noninvasive devices for point-of-care hemoglobin screening in Ghana and Rwanda, as well as the introduction and scale-up of the SILCS single-size contoured diaphragm, This is a “one size fits most” user-friendly, reusable diaphragm that can be used by women seeking safe contraceptive methods. HealthTech V also played a strong leadership role in supporting the introduction and scale-up of chlorhexidine, an important newborn life-saving commodity in numerous developing countries, particularly through the active involvement with the Chlorhexidine Working Group.
- Newborn and child health
- Family planning and reproductive health
- Point-of-care diagnostics
- Health management information system
To learn more about the project and its accomplishments, visit the HealthTech V website.